Sensing Risk: A New Glucose-Ketone Sensor Is the First of Its Kind
Monitoring ketone and glucose levels for people with diabetes just got easier. Abbott, a global medical device company, recently received a CE mark approval for its dual glucose-ketone sensing technology.
As small as a penny, the Libre Duo dual glucose-ketone sensor is the first device that will allow people with diabetes to monitor ketones without traditional blood or urine tests. For people with diabetes, rising ketone levels can lead to a diabetic ketoacidosis (DKA) emergency. The sensor measures levels by the minute, providing real-time visibility of glucose and ketone levels for both users and healthcare professionals.
With the recent CE certification, signifying that this product complies with EU requirements, Abbott plans to begin distributing its Libre Duo sensor in select European countries later this year. Read more.
Learn more about ASG and what we do.
